RU2017123184A - Лечение глазных патологий с применением клеток-предшественников - Google Patents

Лечение глазных патологий с применением клеток-предшественников Download PDF

Info

Publication number
RU2017123184A
RU2017123184A RU2017123184A RU2017123184A RU2017123184A RU 2017123184 A RU2017123184 A RU 2017123184A RU 2017123184 A RU2017123184 A RU 2017123184A RU 2017123184 A RU2017123184 A RU 2017123184A RU 2017123184 A RU2017123184 A RU 2017123184A
Authority
RU
Russia
Prior art keywords
cells
population
tsp
umbilical cord
human umbilical
Prior art date
Application number
RU2017123184A
Other languages
English (en)
Russian (ru)
Other versions
RU2017123184A3 (cg-RX-API-DMAC10.html
Inventor
Надин София ДЕЙНЕКА
Иан ХАРРИС
Original Assignee
Янссен Байотек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Байотек, Инк. filed Critical Янссен Байотек, Инк.
Publication of RU2017123184A publication Critical patent/RU2017123184A/ru
Publication of RU2017123184A3 publication Critical patent/RU2017123184A3/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
    • C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
RU2017123184A 2014-12-05 2015-12-04 Лечение глазных патологий с применением клеток-предшественников RU2017123184A (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462088429P 2014-12-05 2014-12-05
US62/088,429 2014-12-05
US201562126370P 2015-02-27 2015-02-27
US62/126,370 2015-02-27
US201562220873P 2015-09-18 2015-09-18
US62/220,873 2015-09-18
PCT/US2015/063923 WO2016090215A2 (en) 2014-12-05 2015-12-04 Treatment of ocular conditions using progenitor cells

Publications (2)

Publication Number Publication Date
RU2017123184A true RU2017123184A (ru) 2019-01-10
RU2017123184A3 RU2017123184A3 (cg-RX-API-DMAC10.html) 2019-07-17

Family

ID=56092673

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017123184A RU2017123184A (ru) 2014-12-05 2015-12-04 Лечение глазных патологий с применением клеток-предшественников

Country Status (16)

Country Link
US (1) US20160158293A1 (cg-RX-API-DMAC10.html)
EP (1) EP3258946A4 (cg-RX-API-DMAC10.html)
JP (1) JP2017537702A (cg-RX-API-DMAC10.html)
KR (1) KR20170093178A (cg-RX-API-DMAC10.html)
CN (1) CN107206028A (cg-RX-API-DMAC10.html)
AU (1) AU2015358330A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017011513A2 (cg-RX-API-DMAC10.html)
CA (1) CA2969690A1 (cg-RX-API-DMAC10.html)
HK (1) HK1250329A1 (cg-RX-API-DMAC10.html)
MX (1) MX2017007207A (cg-RX-API-DMAC10.html)
PH (1) PH12017500998A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017123184A (cg-RX-API-DMAC10.html)
SG (1) SG11201704268TA (cg-RX-API-DMAC10.html)
TW (1) TW201636032A (cg-RX-API-DMAC10.html)
WO (1) WO2016090215A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201704521B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
JP7348892B2 (ja) * 2019-12-30 2023-09-21 佛教慈濟醫療財團法人 眼疾患を予防または治療する組成物及び方法
WO2021207282A2 (en) * 2020-04-07 2021-10-14 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) * 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
ES2569780T3 (es) * 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
CA2761610C (en) * 2009-05-13 2020-12-29 Medipost Co., Ltd. Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
CN103998048A (zh) * 2011-07-11 2014-08-20 车比奥及戴奥斯泰有限公司 脐带提取物的制备方法和使用方法
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Also Published As

Publication number Publication date
MX2017007207A (es) 2018-01-30
BR112017011513A2 (pt) 2018-07-10
RU2017123184A3 (cg-RX-API-DMAC10.html) 2019-07-17
CN107206028A (zh) 2017-09-26
US20160158293A1 (en) 2016-06-09
TW201636032A (zh) 2016-10-16
EP3258946A4 (en) 2018-08-01
PH12017500998A1 (en) 2017-12-18
SG11201704268TA (en) 2017-06-29
ZA201704521B (en) 2019-01-30
JP2017537702A (ja) 2017-12-21
KR20170093178A (ko) 2017-08-14
WO2016090215A2 (en) 2016-06-09
HK1250329A1 (zh) 2018-12-14
CA2969690A1 (en) 2016-06-09
AU2015358330A1 (en) 2017-06-08
EP3258946A2 (en) 2017-12-27

Similar Documents

Publication Publication Date Title
RU2017124983A (ru) Лечение дегенерации сетчатки с использованием клеток-предшественников
JP2014000094A5 (ja) 臍帯由来細胞を用いた局部的または散在的脳外傷の改善
CA2747794C (en) Treatment of lung and pulmonary diseases and disorders
Pascucci et al. Membrane vesicles mediate pro-angiogenic activity of equine adipose-derived mesenchymal stromal cells
KR20190109389A (ko) 간엽 줄기 세포 집단, 이들의 산물 및 이들의 용도
RU2014150508A (ru) МОДУЛЯЦИЯ hUTC ПРОВОСПАЛИТЕЛЬНЫХ МЕДИАТОРОВ ЛЕГОЧНЫХ И ПУЛЬМОНАЛЬНЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ
JP2014509319A5 (cg-RX-API-DMAC10.html)
RU2013156357A (ru) Лечение дегенеративных изменений межпозвоночных дисков с использованием клеток, полученных из ткани пуповины человека
JP2015159895A5 (cg-RX-API-DMAC10.html)
MY202675A (en) A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium
MX2021003552A (es) Dispositivos implantables para terapia celular y metodos relacionados.
MX2023003296A (es) Generacion de lineas de cardiomiocitos auriculares y ventriculares a partir de celulas madre pluripotentes humanas.
KR20210107144A (ko) 태반 줄기 세포를 이용하는 척수 손상 및 외상성 뇌 손상의 치료
RU2014108878A (ru) Лечение заболевания периферических сосудов при помощи клеток, полученных из ткани пуповины
Yuan et al. The effects of mesenchymal stem cell on colorectal cancer
JP2017537702A5 (cg-RX-API-DMAC10.html)
WO2018158542A8 (fr) Cellules souches mesenchymateuses issues de la gelée de wharton pour le traitement du sepsis
WO2012033352A3 (ko) 말과동물 양수 유래 다분화능 줄기세포 및 그 제조방법
RU2019102933A (ru) Лечение сосудистого заболевания сетчатки с использованием клеток-предшественников
CN104490727A (zh) 一种干细胞与玻尿酸的组合物与应用
RU2018122461A (ru) Лечение дегенерации сетчатки с применением клеток-предшественников
WO2018085516A3 (en) Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases
WO2016093668A3 (ko) 일체형 유전자 치료 유도만능줄기세포 제작방법
SG11201900796UA (en) Prophylactic or therapeutic agent for vascular disorder
Mahdiyar et al. Isolation, culture, and characterization of human dental pulp mesenchymal stem cells

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20191021